I need a freelancer I am a freelancer Pitches

Jyoti Shelar

Mumbai, India
Book Jyoti with Paydesk
See how it works

Book Jyoti with Paydesk

Make your booking securely through paydesk for these benefits:

1

Preferred Booking Channel

Jyoti is more likely to commit to assignments booked through paydesk, as it is a trusted platform that validates the seriousness and legitimacy of each engagement.
2

Insured Bookings for Peace of Mind

We provide basic insurance coverage with each booking on paydesk, giving both you and the media professional confidence and protection while they work for you.
3

Effortless Online Payment

Paydesk offers a payment protection system to ensure payments are only finalized when you are satisfied with the job completion. Freelancers trusts our process that guarantees their efforts are rewarded upon successful delivery of services

Still have questions?

Check FAQ
About Jyoti
Jyoti Shelar is a journalist.
Languages
English Hindi Marathi
Services
News Gathering Feature Stories Research
+3
Skills
Science & Environment Natural Disasters Health & Fitness
+3
Portfolio

What is ‘black fungus’ infection found in India’s COVID patients?

13 May 2021  |  www.aljazeera.com
India is experiencing a surge in mucormycosis, also known as black fungus, among COVID-19 patients. This aggressive fungal infection, which thrives in environments like soil and decaying organic matter, is particularly affecting those with weakened immune systems and diabetes. The western state of Maharashtra has reported around 2,000 cases, prompting the establishment of special hospital wards. The infection is spreading rapidly in other regions, including New Delhi and Gujarat, where hospitals are preparing for more cases and facing shortages of the antifungal drug Amphotericin-B. Treatment is costly, involving surgery and prolonged medication.

The chief medical officer at a Mumbai hospital, honored for her work to fight Covid, died with the disease.

02 May 2021  |  www.nytimes.com
Dr. Manisha Jadhav, the chief medical officer at the Group of Tuberculosis Hospitals in Mumbai, passed away on April 19 due to complications from Covid-19. She was recognized for her significant contributions during the pandemic, including organizing PPE and ensuring staff welfare. Honored by the governor of Maharashtra State, she was one of 13 doctors acknowledged for their efforts. Dr. Jadhav was 51 years old and is survived by her husband.

Oxygen shortage in India’s Maharashtra as COVID cases soar

17 Apr 2021  |  www.aljazeera.com
Maharashtra, India's wealthiest state, is facing a severe oxygen shortage amid a surge in COVID-19 cases. Patients are struggling to find hospital beds and oxygen support, with the state's oxygen usage exceeding its production. The Chief Minister has requested the Prime Minister to deploy the National Disaster Management Authority for airlifting oxygen. Nandurbar district is opening a modified train with 336 beds as an isolation center. The state has imposed new restrictions to curb infections, and Mumbai is using innovative methods to improve bed availability. Despite leading in vaccinations, Maharashtra faces a vaccine shortage, highlighting the need for stronger vaccination efforts and containment measures.

19 Is Surging in India, but Vaccinations Are Slow

21 Mar 2021  |  www.nytimes.com
India is facing a second wave of COVID-19, with daily confirmed infections rising significantly. The vaccination campaign is hindered by a slow government rollout and public skepticism, particularly in densely populated areas like Mumbai's Dharavi slum. The outbreak is concentrated in Maharashtra, leading to renewed lockdowns. Prime Minister Narendra Modi is urging officials to increase testing and vaccinations to prevent economic disruptions similar to last year's nationwide lockdown.

Shorter Breast Cancer Therapy Found Effective, Less Harmful

24 Aug 2018  |  Forbes
Scientists at Tata Memorial Centre in India have discovered that a short-term therapy of three to six months is as effective as the traditional year-long treatment for early-stage HER2-positive breast cancer, with fewer cardiac side effects. The study, which included a meta-analysis of data from multiple clinical trials, suggests that the drug Trastuzumab (brand name Herceptin) can be administered for a shorter period without compromising disease-free survival. This finding could significantly reduce the cost and emotional strain of prolonged treatment for patients. The study was published in the Journal of the American Medical Association and highlights the potential for reduced cardiac toxicity and healthcare expenses. Breast cancer is the most common cancer in women worldwide, with HER2-positive cases making up a significant portion. The high cost of Trastuzumab is a concern, and a shorter treatment duration could alleviate financial burdens for patients.
×

Jyoti's confirmed information

Financial institution
Verified Sep 2020
Joined
Aug 2020

Log in